| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.51▲ | 1.53▼ | 1.53▼ | 1.58▼ | 1.50▲ |
| MA10 | 1.52▼ | 1.52▼ | 1.54▼ | 1.54▼ | 1.59▼ |
| MA20 | 1.53▼ | 1.54▼ | 1.56▼ | 1.53▼ | 1.89▼ |
| MA50 | 1.52▼ | 1.57▼ | 1.56▼ | 1.64▼ | 1.58▼ |
| MA100 | 1.54▼ | 1.56▼ | 1.53▼ | 1.94▼ | 1.95▼ |
| MA200 | 1.56▼ | 1.53▼ | 1.55▼ | 1.73▼ | 4.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.001▲ | -0.006▼ | 0.015▲ | -0.062▼ |
| RSI | 43.898▼ | 43.780▼ | 43.137▼ | 46.181▼ | 43.672▼ |
| STOCH | 9.583▼ | 68.790 | 35.417 | 49.769 | 17.829▼ |
| WILL %R | -66.667 | -66.667 | -66.667 | -62.500 | -85.326▼ |
| CCI | -82.963 | -62.997 | -74.468 | -27.008 | -70.957 |
|
Wednesday, February 04, 2026 05:18 AM
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel ...
|
|
Tuesday, January 13, 2026 09:00 AM
Caribou Biosciences, Inc. (CRBU) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
|
|
Sunday, November 16, 2025 04:00 PM
The average one-year price target for Caribou Biosciences (NasdaqGS:CRBU) has been revised to $11.35 / share. This is an increase of 25.61% from the prior estimate of $9.03 dated November 7, 2025. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/02/26 | 1.56 | 1.56 | 1.47 | 1.515 | 785,164 |
| 11/02/26 | 1.58 | 1.60 | 1.475 | 1.59 | 1,121,088 |
| 10/02/26 | 1.63 | 1.63 | 1.57 | 1.57 | 1,357,746 |
| 09/02/26 | 1.58 | 1.65 | 1.53 | 1.63 | 760,849 |
| 06/02/26 | 1.52 | 1.58 | 1.495 | 1.57 | 1,015,727 |
| 05/02/26 | 1.60 | 1.645 | 1.45 | 1.48 | 1,268,066 |
| 04/02/26 | 1.59 | 1.64 | 1.49 | 1.62 | 2,184,501 |
| 03/02/26 | 1.555 | 1.74 | 1.48 | 1.56 | 2,391,289 |
| 02/02/26 | 1.40 | 1.48 | 1.38 | 1.46 | 1,157,479 |
| 30/01/26 | 1.46 | 1.47 | 1.39 | 1.41 | 790,200 |
|
|
||||
|
|
||||
|
|